Basic Information
RNALocate ID: | RLID:11001624 |
RNA Symbol: | hsa-let-7g-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-let-7g |
RNA ID: | miRBase:MIMAT0000414 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 20976003 |
Tissue/Cell Line: | Breast cancer cell line (MCF-7) |
Method: | Microarray |
Description: | Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001694 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001695 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001696 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001697 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
RLID:01001698 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
RLID:01001699 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001700 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001701 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001702 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001703 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001704 | Nucleus | HeLa cells | 22058130 |
RLID:11001622 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11001623 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11001625 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001626 | Exosome | Renal cancer cells | 21670082 |
RLID:11001627 | Exosome | Breast milk | 22211110 |
RLID:11001628 | Exosome | Epidermal melanocytes (HEMa-LP)|Malignant melanoma cell line (A375) | 23056502 |
RLID:11001629 | Exosome | Saliva | 23302638 |
RLID:11001630 | Exosome | Brain tissue | 23382797 |
RLID:11001631 | Exosome | Plasma | 23663360 |
RLID:11001632 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11001633 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001634 | Microvesicle | Plasma | 19002258 |
RLID:11001635 | Microvesicle | Plasma | 23077538 |
RLID:11001636 | Microvesicle | Seminal plasma | 23539611 |
RLID:11001637 | Microvesicle | Follicular fluid | 23666971 |
RLID:11001638 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000068 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000342 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7g-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01982 |
MNDR | hsa-let-7g-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01983 |
MNDR | hsa-let-7g-5p | Oral squamous cell carcinoma | MNDR-E-MI-01984 |
MNDR | hsa-let-7g-5p | B cell lymphoma of malt type | MNDR-E-MI-01985 |
MNDR | hsa-let-7g-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-01986 |
MNDR | hsa-let-7g-5p | Lymphoma | MNDR-E-MI-01987 |
MNDR | hsa-let-7g-5p | Lymphoma non-hodgkin | MNDR-E-MI-01988 |
MNDR | hsa-let-7g-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01989 |
MNDR | hsa-let-7g-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01990 |
MNDR | hsa-let-7g-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01991 |
MNDR | hsa-let-7g-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01992 |
MNDR | hsa-let-7g-5p | Breast cancer luminal | MNDR-E-MI-01993 |
MNDR | hsa-let-7g-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-01994 |
MNDR | hsa-let-7g-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-01995 |
MNDR | hsa-let-7g-5p | Prostate cancer | MNDR-E-MI-01996 |
MNDR | hsa-let-7g-5p | Gastric cancer | MNDR-E-MI-01997 |
MNDR | hsa-let-7g-5p | Gastric lymphoma | MNDR-E-MI-01998 |
MNDR | hsa-let-7g-5p | Alzheimer disease | MNDR-E-MI-01999 |
MNDR | hsa-let-7g-5p | Dysautonomia familial | MNDR-E-MI-02000 |
MNDR | hsa-let-7g-5p | Head and neck cancer | MNDR-E-MI-02001 |
MNDR | hsa-let-7g-5p | Malaria | MNDR-E-MI-02002 |
MNDR | hsa-let-7g-5p | Leukemia | MNDR-E-MI-02003 |
MNDR | hsa-let-7g-5p | Cardiovascular disease | MNDR-E-MI-02004 |
MNDR | hsa-let-7g-5p | Lung cancer | MNDR-E-MI-02005 |
MNDR | hsa-let-7g-5p | Metabolic syndrome x | MNDR-E-MI-02006 |
MNDR | hsa-let-7g-5p | Parkinson disease | MNDR-E-MI-02007 |
MNDR | hsa-let-7g-5p | Breast cancer | MNDR-E-MI-02008 |
MNDR | hsa-let-7g-5p | Thyroid cancer | MNDR-E-MI-02009 |
MNDR | hsa-let-7g-5p | Pancreatic cancer | MNDR-E-MI-02010 |
MNDR | hsa-let-7g-5p | Melanoma | MNDR-E-MI-02011 |
MNDR | hsa-let-7g-5p | Rectum adenocarcinoma | MNDR-E-MI-02012 |
MNDR | hsa-let-7g-5p | Nephroblastoma | MNDR-E-MI-02013 |
MNDR | hsa-let-7g-5p | Colon cancer | MNDR-E-MI-02014 |
MNDR | hsa-let-7g-5p | Ischemic attack transient | MNDR-E-MI-02015 |
MNDR | hsa-let-7g-5p | Colon adenocarcinoma | MNDR-E-MI-02016 |
MNDR | hsa-let-7g-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02017 |
MNDR | hsa-let-7g-5p | Familial ovarian cancer | MNDR-E-MI-02018 |
MNDR | hsa-let-7g-5p | Prostate adenocarcinoma | MNDR-E-MI-02019 |
MNDR | hsa-let-7g-5p | Carcinoma ductal breast | MNDR-E-MI-02020 |
MNDR | hsa-let-7g-5p | Glioblastoma | MNDR-E-MI-02021 |
MNDR | hsa-let-7g-5p | Malignant glioma | MNDR-E-MI-02022 |
MNDR | hsa-let-7g-5p | Chordoma | MNDR-E-MI-02023 |
MNDR | hsa-let-7g-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02024 |
MNDR | hsa-let-7g-5p | Liposarcoma | MNDR-E-MI-02025 |
MNDR | hsa-let-7g-5p | Liver cancer | MNDR-E-MI-02026 |
MNDR | hsa-let-7g-5p | Uterine cancer | MNDR-E-MI-02027 |
MNDR | hsa-let-7g-5p | Cervical adenocarcinoma | MNDR-E-MI-02028 |
MNDR | hsa-let-7g-5p | Gastric adenocarcinoma | MNDR-E-MI-02029 |
MNDR | hsa-let-7g-5p | Non-small cell lung cancer | MNDR-E-MI-02030 |
MNDR | hsa-let-7g-5p | Lung adenocarcinoma | MNDR-E-MI-02031 |
MNDR | hsa-let-7g-5p | Adrenocortical cancer | MNDR-E-MI-02032 |
MNDR | hsa-let-7g-5p | Thyroid carcinoma | MNDR-E-MI-02033 |
MNDR | hsa-let-7g-5p | Tuberculosis | MNDR-E-MI-02034 |
MNDR | hsa-let-7g-5p | Carcinoma renal cell | MNDR-E-MI-02035 |
MNDR | hsa-let-7g-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02036 |
MNDR | hsa-let-7g-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02037 |
MNDR | hsa-let-7g-5p | Biliary tract cancer | MNDR-E-MI-02038 |
MNDR | hsa-let-7g-5p | Cholangiocarcinoma | MNDR-E-MI-02039 |
MNDR | hsa-let-7g-5p | Esophageal cancer | MNDR-E-MI-02040 |
MNDR | hsa-let-7g-5p | Liver cirrhosis | MNDR-E-MI-02041 |
MNDR | hsa-let-7g-5p | Testicular germ cell cancer | MNDR-E-MI-02042 |
MNDR | hsa-let-7g-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02043 |
MNDR | hsa-let-7g-5p | Acute t cell leukemia | MNDR-E-MI-02044 |
MNDR | hsa-let-7g-5p | Breast invasive carcinoma | MNDR-E-MI-02045 |
MNDR | hsa-let-7g-5p | Early hepatocellular carcinoma | MNDR-E-MI-02046 |
MNDR | hsa-let-7g-5p | Familiar ovarian carcinoma | MNDR-E-MI-02047 |
MNDR | hsa-let-7g-5p | B-cell lymphoma | MNDR-E-MI-02048 |
MNDR | hsa-let-7g-5p | Rheumatoid arthritis | MNDR-E-MI-02049 |
MNDR | hsa-let-7g-5p | T-cell leukemia | MNDR-E-MI-02050 |
MNDR | hsa-let-7g-5p | Neuroblastoma | MNDR-E-MI-02051 |
MNDR | hsa-let-7g-5p | Hodgkin lymphoma | MNDR-E-MI-02052 |
MNDR | hsa-let-7g-5p | Burkitt lymphoma | MNDR-E-MI-02053 |
MNDR | hsa-let-7g-5p | Neurological disease | MNDR-E-MI-02054 |
MNDR | hsa-let-7g-5p | Crohn disease | MNDR-E-MI-02055 |
MNDR | hsa-let-7g-5p | Neuromyelitis optica | MNDR-E-MI-02056 |
MNDR | hsa-let-7g-5p | Acute myelogenous leukemia | MNDR-E-MI-02057 |
MNDR | hsa-let-7g-5p | Colorectal cancer | MNDR-E-MI-02058 |
MNDR | hsa-let-7g-5p | Nasopharynx carcinoma | MNDR-E-MI-02059 |
MNDR | hsa-let-7g-5p | Multiple myeloma | MNDR-E-MI-02060 |
MNDR | hsa-let-7g-5p | Nasopharyngeal cancer | MNDR-E-MI-02061 |
MNDR | hsa-let-7g-5p | Prostatic neoplasms | MNDR-E-MI-02062 |
MNDR | hsa-let-7g-5p | High grade dysplastic nodule | MNDR-E-MI-02063 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCC10 | Homo sapiens | RR00023406 |
TOP